• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STAT1-CCL5轴的上调是结肠癌的一个生物标志物,并促进结肠癌细胞的增殖。

Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells.

作者信息

Niu Mengke, Yi Ming, Dong Bing, Luo Suxia, Wu Kongming

机构信息

Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Ann Transl Med. 2020 Aug;8(15):951. doi: 10.21037/atm-20-4428.

DOI:10.21037/atm-20-4428
PMID:32953751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7475405/
Abstract

BACKGROUND

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and women globally. Investigating genetic ground differences between normal and CRC tissues would be significant for identifying some key oncogenic pathways and developing anti-cancer agents.

METHODS

Weighted gene co-expression network analysis (WGCNA) method was used to screen out core pathways related to the clinical traits of CRC patients. Then, multiple databases were utilized to further verify the hub genes obtained from data mining. Finally, to explore the role of hub genes in CRC, cell counting and EdU assays were performed.

RESULTS

The results of the WGCNA analysis showed that a module (turquoise module) was highly related with CRC differentiation grade (R =0.53, P<0.0001). Enrichment analysis indicated that genes of the turquoise module were remarkably enriched in multiple inflammatory processes and pathways. Among all hub genes of the turquoise module, the mRNA levels of and were significantly higher in CRC than in normal colon tissues. expression was highly positively correlated with the level of . The results of the cell counting, EdU, CCK-8, and CFSE staining assays showed that interfering with STAT1 and CCL5 could inhibit the proliferation of CRC cells.

CONCLUSIONS

Our study indicated that the STAT1-CCL5 axis is an important modulator in the development of CRC through promoting cell proliferation. Moreover, the levels of STAT1 and CCL5 might be valuable biomarkers for CRC screening.

摘要

背景

结直肠癌(CRC)是全球男性和女性中第三大最常被诊断出的癌症。研究正常组织与CRC组织之间的基因差异对于识别一些关键致癌途径和开发抗癌药物具有重要意义。

方法

使用加权基因共表达网络分析(WGCNA)方法筛选出与CRC患者临床特征相关的核心途径。然后,利用多个数据库进一步验证从数据挖掘中获得的枢纽基因。最后,为了探究枢纽基因在CRC中的作用,进行了细胞计数和EdU检测。

结果

WGCNA分析结果显示,一个模块(绿松石模块)与CRC分化程度高度相关(R = 0.53,P < 0.0001)。富集分析表明,绿松石模块的基因在多个炎症过程和途径中显著富集。在绿松石模块的所有枢纽基因中,CRC中 和 的mRNA水平显著高于正常结肠组织。 的表达与 的水平高度正相关。细胞计数、EdU、CCK - 8和CFSE染色检测结果表明,干扰STAT1和CCL5可抑制CRC细胞的增殖。

结论

我们的研究表明,STAT1 - CCL5轴通过促进细胞增殖是CRC发生发展中的重要调节因子。此外,STAT1和CCL5的水平可能是CRC筛查中有价值的生物标志物。

相似文献

1
Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells.STAT1-CCL5轴的上调是结肠癌的一个生物标志物,并促进结肠癌细胞的增殖。
Ann Transl Med. 2020 Aug;8(15):951. doi: 10.21037/atm-20-4428.
2
A role of TTI1 in the colorectal cancer by promoting proliferation.TTI1通过促进增殖在结直肠癌中发挥作用。
Transl Cancer Res. 2021 Mar;10(3):1378-1388. doi: 10.21037/tcr-20-3322.
3
Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.通过共表达网络分析鉴定早发性结直肠癌发生发展过程中的关键基因
Oncol Lett. 2020 Jan;19(1):177-186. doi: 10.3892/ol.2019.11073. Epub 2019 Nov 8.
4
Holistic exploration of and hsa-miR-137 in colorectal cancer via multi-omic data Integration.通过多组学数据整合对结直肠癌中的[具体内容]和hsa-miR-137进行全面探索。 (注:原文中“Holistic exploration of and”这里“of”后面似乎缺失了关键信息)
Heliyon. 2024 Mar 3;10(5):e27046. doi: 10.1016/j.heliyon.2024.e27046. eCollection 2024 Mar 15.
5
STAT1: a novel candidate biomarker and potential therapeutic target of the recurrent aphthous stomatitis.STAT1:复发性阿弗他口炎的新型候选生物标志物和潜在治疗靶点。
BMC Oral Health. 2021 Oct 14;21(1):524. doi: 10.1186/s12903-021-01776-w.
6
Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation and .通过整合加权基因共表达网络分析和临床验证来鉴定结直肠癌中的枢纽基因 以及 。 你提供的原文似乎不太完整,翻译可能会存在一定局限性。
Front Oncol. 2020 Apr 30;10:638. doi: 10.3389/fonc.2020.00638. eCollection 2020.
7
Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.加权基因共表达网络分析揭示了与肥厚型心肌病诊断相关的关键生物标志物。
Hereditas. 2020 Oct 24;157(1):42. doi: 10.1186/s41065-020-00155-9.
8
Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.加权基因共表达网络分析表明,MYL9和CNN1与结直肠癌复发相关。
J Cancer. 2020 Feb 10;11(8):2348-2359. doi: 10.7150/jca.39723. eCollection 2020.
9
Identification of key gene modules and genes in colorectal cancer by co-expression analysis weighted gene co-expression network analysis.基于加权基因共表达网络分析的结直肠癌关键基因模块和基因的鉴定。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20202044.
10
Identification of 10 Hub genes related to the progression of colorectal cancer by co-expression analysis.通过共表达分析鉴定与结直肠癌进展相关的10个枢纽基因。
PeerJ. 2020 Jul 28;8:e9633. doi: 10.7717/peerj.9633. eCollection 2020.

引用本文的文献

1
Knockdown of miR-411-3p induces M2 macrophage polarization and promotes colorectal cancer progression by regulation of MMP7.敲低miR-411-3p可诱导M2巨噬细胞极化,并通过调节MMP7促进结直肠癌进展。
Eur J Histochem. 2025 Apr 7;69(2). doi: 10.4081/ejh.2025.4178. Epub 2025 May 5.
2
Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer.mRNA和蛋白质标志物与胰腺癌复发部位的网络动力学及治疗方面
Heliyon. 2024 May 17;10(10):e31437. doi: 10.1016/j.heliyon.2024.e31437. eCollection 2024 May 30.
3
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.

本文引用的文献

1
The expression profile of RNA sensors in colorectal cancer and its correlation with cancer stages.RNA传感器在结直肠癌中的表达谱及其与癌症分期的相关性。
Transl Cancer Res. 2019 Aug;8(4):1351-1363. doi: 10.21037/tcr.2019.07.45.
2
Concise update on colorectal cancer epidemiology.结直肠癌流行病学的简要更新。
Ann Transl Med. 2019 Nov;7(21):609. doi: 10.21037/atm.2019.07.91.
3
Programmed colorectal cancer screening decreases incidence and mortality.计划性结直肠癌筛查可降低发病率和死亡率。
进展期治疗抵抗性 MSI-H 结直肠癌患者的基于 TCR 的 T 细胞一过性治疗。
Mol Ther. 2024 Jun 5;32(6):2021-2029. doi: 10.1016/j.ymthe.2024.04.009. Epub 2024 Apr 6.
4
Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes.NLRP6炎性小体表达降低与2型糖尿病肥胖患者肠道通透性增加和炎症相关。
Cell Mol Life Sci. 2024 Feb 5;81(1):77. doi: 10.1007/s00018-024-05124-3.
5
Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development.抑制 CDKL3 下调 STAT1 的表达,从而抑制前列腺癌的发展。
Cell Death Dis. 2023 Mar 10;14(3):189. doi: 10.1038/s41419-023-05694-3.
6
Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression.肿瘤细胞来源的乳酸诱导肿瘤相关巨噬细胞中高迁移率族蛋白 1 的上调进一步促进结直肠癌的进展。
J Transl Med. 2023 Jan 28;21(1):53. doi: 10.1186/s12967-023-03918-w.
7
A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer.结直肠癌免疫治疗的一个有前景的研究方向:CCL5在结直肠癌中的调控机制
Front Oncol. 2022 Nov 1;12:1020400. doi: 10.3389/fonc.2022.1020400. eCollection 2022.
8
A chemical probe inhibitor targeting STAT1 restricts cancer stem cell traits and angiogenesis in colorectal cancer.针对 STAT1 的化学探针抑制剂限制结直肠癌中的癌症干细胞特性和血管生成。
J Biomed Sci. 2022 Mar 22;29(1):20. doi: 10.1186/s12929-022-00803-4.
9
Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.肿瘤芽衍生的 CCL5 通过 CCR5-SLC25A24 信号招募成纤维细胞并促进结直肠癌进展。
J Exp Clin Cancer Res. 2022 Mar 3;41(1):81. doi: 10.1186/s13046-022-02300-w.
10
Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.伊立替康/scFv 共载脂质体协同作用于肿瘤细胞和 CAFs 以增强结直肠癌治疗。
J Nanobiotechnology. 2021 Dec 14;19(1):421. doi: 10.1186/s12951-021-01172-0.
Transl Gastroenterol Hepatol. 2019 Dec 26;4:84. doi: 10.21037/tgh.2019.12.13. eCollection 2019.
4
Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages.CCL5 对乳腺癌生物学行为的影响及其与肿瘤相关巨噬细胞相互作用的机制。
Oncol Rep. 2019 Dec;42(6):2499-2511. doi: 10.3892/or.2019.7344. Epub 2019 Oct 1.
5
Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway.拓扑异构酶抑制剂通过 ROS 介导的 JAK2-STAT1-CXCL1 通路激活促进癌细胞迁移。
J Exp Clin Cancer Res. 2019 Aug 22;38(1):370. doi: 10.1186/s13046-019-1353-2.
6
EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival.EYA2与乳腺癌的临床病理特征相关,促进肿瘤增殖,并预示生存不良。
Front Oncol. 2019 Jan 29;9:26. doi: 10.3389/fonc.2019.00026. eCollection 2019.
7
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
8
Promising New Agents for Colorectal Cancer.用于结直肠癌的有前途的新药物。
Curr Treat Options Oncol. 2018 May 11;19(6):29. doi: 10.1007/s11864-018-0543-z.
9
DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.DACH1 通过拮抗 CXCL8 抑制肺腺癌的肿瘤发生并改善预后。
J Hematol Oncol. 2018 Apr 10;11(1):53. doi: 10.1186/s13045-018-0597-1.
10
Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.白细胞介素 35 在胰腺导管腺癌中的表达与微血管密度相关,募集单核细胞,并促进小鼠异种移植肿瘤的生长和血管生成。
Gastroenterology. 2018 Feb;154(3):675-688. doi: 10.1053/j.gastro.2017.09.039. Epub 2017 Oct 6.